GMGcobisa MadloloSlidesetHIVHIV Prevention Summit 2021Successes to Access PrEP and PEP End-User Perspective_Gcobisa MadloloView Slideset
RMGRoy M. GulickMD, MPHSlidesetHIVHIV Prevention Summit 2021Overview of Clinical Data on the Safety and Efficacy of Antiretroviral Drugs for HIV - Roy M. Gulick, MD, MPHView Slideset
CFCharles FlexnerMDSlidesetHIVHIV Prevention Summit 2021Novel Drug Delivery Systems on the Horizon -Charles Flexner, MDView Slideset
MSCMyron S. CohenMD, BSSlidesetHIVHIV Prevention Summit 2021Antibody Mediated Prevention of HIV - Myron Cohen, MDView Slideset
SlidesetHIVHIV Prevention Summit 2021Successes to Access PrEP and PEP End-User Perspective - Gcobisa MadloloView Slideset
SlidesetHIVHIV Prevention Summit 2021WHO Perspective on HIV Prevention - What Are the Gaps - Rachel Baggaley, MBBS, MScView Slideset
SlidesetHIVHIV Prevention Summit 2021Non-Occupational Post-Exposure Prophylaxis, Post-Violence Care and Ongoing HIV Risk in Kampala Uganda: Missed Opportunities for HIV Prevention through Pre-Exposure Prophylaxis and Other Interventions - Lisa MillsView Slideset
SlidesetHIVHIV Prevention Summit 2021Uptake of HIV post-exposure prophylaxis, completion rates and selfreported reasons for non-completion among health care workers at Mbarara Regional Referral Hospital - Musiime Muzoora DanView Slideset
SlidesetHIVHIV Prevention Summit 2021Intimate partner violence and gender-based violence among people living with HIV in southern Nigeria - Chika OkaforView Slideset
SlidesetHIVHIV Prevention Summit 2021Community PrEP Service delivery for Female Sex Workers in Ghana - Guro Lundby SorensenView Slideset
SlidesetHIVHIV Prevention Summit 2021Persistence on F/TAF versus F/TDF for HIV Pre-Exposure Prophylaxis: A Real-World Evidence Analysis in the United States - Corie Cruz BeniasiansView Slideset
SlidesetHIVHIV Prevention Summit 2021Socio-Demographics of Individuals Initiated on HIV pre-exposure prophylaxis (PrEP) in Nigeria - Augustine IdemudiaView Slideset
